In accordance with regulation 74(5) of the DP Regulations and based on the certificate received from Link Intime India (RTA), Zydus Lifesciences has confirmed that for the quarter ended on March 31, 2024, the certificates of equity shares received for dematerialization have been mutilated and cancelled only after due verification and that the name of the respective depository has been substituted as the registered owner in respect of those dematerialized equity shares. They further confirmed that the securities comprised in the said certificates of equity shares have been listed on BSE and the National Stock Exchange of India where the earlier issued securities are listed.
The above information is a part of company’s filings submitted to BSE.
